View in EDS PDF Full Text

Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.
Authors: Casanova AG; Toxicology Unit, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain., Morales AI; Toxicology Unit, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain.; Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain., Vicente-Vicente L; Toxicology Unit, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain., López-Hernández FJ; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain.; Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain.
Source: Frontiers in pharmacology [Front Pharmacol] 2024 Mar 26; Vol. 15, pp. 1373258. Date of Electronic Publication: 2024 Mar 26 (Print Publication: 2024).
Publication Type: Systematic Review; Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38601468
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Casanova+AG%22">Casanova AG</searchLink>; Toxicology Unit, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Morales+AI%22">Morales AI</searchLink>; Toxicology Unit, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain.; Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain.<br /><searchLink fieldCode="AU" term="%22Vicente-Vicente+L%22">Vicente-Vicente L</searchLink>; Toxicology Unit, Universidad de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22López-Hernández+FJ%22">López-Hernández FJ</searchLink>; Instituto de Investigación Biomédica de Salamanca (IBSAL) del Instituto de Ciencias de la Salud de Castilla y León (ICSCYL), Salamanca, Spain.; Department of Physiology and Pharmacology, Universidad de Salamanca (USAL), Salamanca, Spain.; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.; National Network for Kidney Research REDINREN, RICORS2040 RD21/0005/0004-Instituto de Salud Carlos III, Madrid, Spain.; Group of Biomedical Research on Critical Care (BioCritic), Valladolid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2024 Mar 26; Vol. 15, pp. 1373258. <i>Date of Electronic Publication: </i>2024 Mar 26 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Systematic Review; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38601468
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2024.1373258
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1373258
    Titles:
      – TitleFull: Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Casanova AG
      – PersonEntity:
          Name:
            NameFull: Morales AI
      – PersonEntity:
          Name:
            NameFull: Vicente-Vicente L
      – PersonEntity:
          Name:
            NameFull: López-Hernández FJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 03
              Text: 2024 Mar 26
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1